develop
strategi
augment
immunogen
dna
vaccin
critic
improv
clinic
util
one
strategi
involv
use
differ
immun
rout
dna
vaccin
present
studi
immunogen
sarscov
nucleocapsid
dna
vaccin
induc
use
current
routin
vaccin
rout
intramuscularli
electropor
oral
use
liveattenu
salmonella
typhimurium
compar
mous
model
comparison
three
vaccin
rout
indic
immun
intramuscularli
induc
moder
cell
respons
antibodi
respons
mice
administr
electropor
induc
highest
antibodi
respons
among
three
immun
group
midlevel
cellular
respons
contrast
oral
dna
vaccin
evok
vigor
cell
respons
weak
antibodi
product
result
indic
distinct
type
immun
respons
gener
differ
rout
dna
immun
addit
result
also
show
deliveri
dna
vaccin
electropor
oral
use
liveattenu
salmonella
vivo
effect
method
increas
immun
respons
studi
could
carri
use
combin
strategi
oral
electropor
immun
stimul
higher
cellular
humor
immun
respons
sever
acut
respiratori
syndrom
sar
new
emerg
infecti
diseas
led
thousand
human
infect
hundr
death
year
caus
agent
sar
identifi
novel
coronaviru
name
sarscov
sarscov
phylogenet
differ
member
coronavirida
famili
coronaviru
current
known
caus
sever
morbid
mortal
human
although
sar
epidem
success
contain
juli
pathogenesi
sarscov
remain
poorli
understood
effect
treatment
sar
current
prevent
contactreduct
transmissionblock
measur
import
mean
avail
modifi
devast
impact
ill
prevent
vaccin
would
attract
altern
less
reliant
individu
case
detect
effect
sarscov
genom
contain
four
major
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
n
protein
mani
coronavirus
highli
immunogen
abundantli
express
infect
n
protein
felin
infecti
periton
viru
fipv
use
subunit
vaccin
induc
protect
immun
prevent
progress
diseas
cat
model
porcin
coronaviru
transmiss
gastroenter
viru
tgev
n
protein
repres
antigen
cell
respons
may
induc
cellular
humor
immun
respons
result
indic
good
n
protein
vaccin
candid
elicit
strong
immun
respons
sarscov
n
protein
highli
conserv
within
differ
isol
share
amino
acid
homolog
n
protein
coronavirus
thu
n
protein
import
target
sarscov
vaccin
develop
immunogen
sarscov
n
protein
investig
long
time
antibodi
n
protein
longer
live
occur
greater
abund
sar
patient
antibodi
viral
compon
e
protein
previou
studi
n
protein
repres
antigen
cell
respons
vaccin
set
mice
vaccin
calreticulin
crt
n
dna
capabl
significantli
reduc
titer
challeng
vaccinia
viru
express
n
protein
sar
viru
report
n
dna
vaccin
could
induc
sarsspecif
cell
prolifer
cytotox
cell
activ
experi
demonstr
sarsn
administr
could
induc
virusspecif
cellular
respons
human
cell
use
scidpblhumous
model
therefor
base
observ
initi
focus
sarscov
n
protein
target
antigen
dna
vaccin
develop
report
dna
vaccin
practic
effect
way
induc
humor
cellular
immun
respons
shown
great
promis
protect
immun
respons
sever
diseas
experiment
anim
model
includ
hiv
tuberculosi
malaria
sever
rout
method
dna
immun
shown
gener
ab
th
cell
ctl
respons
apart
convent
intramuscular
immun
recent
experi
demonstr
electropor
greatli
enhanc
plasmid
vaccin
associ
increas
level
gene
express
addit
electropor
display
adjuv
qualiti
increas
gene
express
anoth
conveni
dna
vaccin
deliveri
system
oral
vaccin
use
liveattenu
salmonella
typhimurium
use
attenu
strain
salmonella
vehicl
deliv
plasmid
dna
vivo
effect
method
induc
strong
cellmedi
humor
immun
respons
mucos
site
thu
particularli
interest
electropor
immun
oral
immun
liveattenu
typhimurium
vivo
studi
directli
compar
immun
respons
gener
differ
vaccin
mean
sarscov
dna
immun
studi
immunogen
sarscov
nucleocapsid
dna
vaccin
deliv
intramuscularli
electropor
oral
liveattenu
typhimurium
compar
mous
model
mammalian
express
vector
invitrogen
carlsbad
calif
use
dna
vaccin
studi
current
experi
gener
recombin
plasmid
pcdnan
dna
fragment
encod
sarscov
nucleocapsid
amplifi
pcr
cdna
sarscov
strain
primer
follow
gca
ggt
acc
atg
tct
gat
aat
gga
ccc
gcg
aga
tct
tta
tgc
ctg
agt
tga
atc
accuraci
construct
confirm
restrict
digest
sequenc
recombin
plasmid
amplifi
escherichia
coli
purifi
use
qiagen
megaprep
column
qiagen
purifi
plasmid
dissolv
endotoxinfre
pb
final
concentr
gl
store
c
attenu
thyphimurium
strain
atcc
phop
c
kindli
provid
prof
guo
aizhen
huazhong
agricultur
univers
school
anim
medicin
wuhan
pr
use
carrier
oral
genet
immun
express
recombin
n
protein
mammalian
cell
vitro
analyz
cell
transfect
carri
lipofectin
reagent
accord
procedur
describ
manufactur
gibco
brl
gaithersburg
md
brief
sixwel
tissu
cultur
plate
seed
cell
ml
dulbecco
modifi
eagl
medium
dmem
gibco
invitrogen
supplement
fetal
bovin
serum
fb
gibco
invitrogen
cell
incub
c
co
cultur
confluent
g
purifi
recombin
plasmid
l
lipofectin
reagent
mix
l
fb
free
medium
respect
incub
min
room
temperatur
incub
l
fb
free
dmem
ad
entir
mixtur
overlaid
onto
cell
incub
h
c
mixtur
replac
ml
dmem
contain
fb
incub
examin
cell
harvest
western
blot
analysi
h
transfect
western
blot
analysi
cell
lysat
load
onto
polyacrylamid
gel
transfer
onto
polyvinyliden
fluorid
pvdf
membran
amersham
stain
use
rat
antin
antibodi
primari
antibodi
eightweekold
femal
balbc
mice
purchas
center
experiment
anim
hubei
medic
colleg
randomli
divid
six
group
anim
per
group
anim
provid
pathogenfre
water
food
mice
immun
three
time
interv
intramuscularli
im
electropor
oral
typhimurium
intramuscularli
vaccin
group
immun
dose
g
plasmid
per
anim
inject
quadricep
muscl
electropor
immun
anim
anesthet
inject
g
pcdnan
plasmid
intramuscularli
rear
thigh
twoneedl
array
electrod
insert
muscl
immedi
inject
dna
electropor
vivo
electropor
perform
btx
squar
wave
gener
btx
san
diego
ca
paramet
vmm
distanc
electrod
puls
length
puls
revers
polar
puls
oral
immun
attenu
salmonella
strain
harbor
pcdnan
dna
vaccin
cultur
grown
reach
od
cell
harvest
centrifug
resuspend
highest
requir
densiti
phosphatebuff
salin
pb
sigma
inoculum
typhimurium
dilut
appropri
concentr
ml
sodium
bicarbon
nahco
buffer
mous
immun
oral
gavag
cfu
typhimurium
transform
pcdnan
dna
dosag
cfu
attenu
typhimurium
use
immun
group
optim
seri
preliminari
experi
mice
group
bled
day
blood
isol
store
c
antibodi
measur
antin
antibodi
level
serum
assess
enzymelink
immunosorb
assay
elisa
n
protein
express
e
coli
use
detect
antigen
vector
new
england
biolab
use
express
n
protein
e
coli
express
fusion
protein
includ
maltosebind
protein
mbp
n
protein
purifi
amylos
column
accord
manufactur
instruct
new
england
biolab
optim
concentr
gml
antigen
coat
onto
plate
costar
overnight
c
plate
wash
block
bsa
buffer
solut
h
c
prior
incub
dilut
mous
sera
c
bound
antibodi
detect
alkalin
phosphataseconjug
goat
antimous
igg
sigma
color
develop
ad
paranitrophenyl
phosphat
pnpp
substrat
absorb
read
nm
use
plate
reader
biorad
usa
valu
obtain
mous
sera
experiment
group
consid
posit
time
control
group
valu
includ
similar
elisa
protocol
follow
assess
nspecif
immunoglobulin
igg
subclass
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
sigma
use
secondari
antibodi
optic
densiti
od
read
nm
antigenspecif
cell
prolifer
lpa
assay
perform
describ
previous
brief
day
follow
final
inject
mice
sacrif
singlecel
suspens
prepar
spleen
group
splenocyt
per
well
medium
sigma
supplement
fb
seed
plate
triplic
cultur
stimul
follow
variou
condit
h
c
co
gml
concanavalin
posit
control
gml
purifi
n
protein
specif
antigen
gml
bovin
serum
albumin
irrelev
antigen
medium
alon
neg
control
celltit
aqueou
one
solut
reagent
l
promega
usa
ad
well
accord
manufactur
protocol
follow
incub
c
absorb
read
nm
prolif
activ
estim
use
stimul
index
si
calcul
mean
od
antigencontain
well
divid
mean
od
well
without
antigen
cellular
immun
respons
n
protein
assess
elispot
assay
use
mous
splenocyt
assay
perform
accord
instruct
manual
ucytech
netherland
ninetysixwel
plate
coat
gml
rat
antimous
lwell
pb
overnight
plate
wash
three
time
pb
contain
block
pb
contain
fb
h
c
three
wash
pb
contain
splenocyt
l
reaction
buffer
contain
gml
purifi
nprotein
ad
well
plate
incub
h
c
co
wash
time
pb
biotinyl
antimous
mab
dilut
subsequ
ad
plate
incub
h
room
temperatur
wash
avidinhorseradish
peroxidas
ad
addit
hour
incub
room
temperatur
follow
five
wash
pb
individu
plate
develop
dark
spot
reaction
peroxidas
substrat
aec
reaction
stop
rins
plate
deminer
water
plate
airdri
room
temperatur
absorb
read
use
elispot
reader
hitech
instrument
spotform
cell
sfc
per
splenocyt
calcul
medium
background
consist
sfc
per
splenocyt
data
present
mean
sd
immun
mice
per
group
spss
softwar
window
use
statist
analysi
differ
humor
cellular
immun
respons
group
assess
use
singl
factor
analysi
varianc
lsd
ttest
use
group
comparison
pvalu
consid
statist
signific
pcdnan
construct
transient
transfect
cell
express
effici
n
protein
detect
western
blot
western
blot
result
see
strong
specif
protein
band
sarscov
n
protein
detect
lane
fig
cell
transfect
show
crossreact
sarscov
n
polyclon
serum
lane
fig
express
dna
construct
analyz
vitro
balbc
mice
inocul
mice
intramuscularli
electropor
oral
use
attenu
typhimurium
interv
examin
humor
respons
elicit
differ
vaccin
rout
sarscov
nspecif
antibodi
analyz
indirect
elisa
sera
sampl
collect
day
first
immun
found
blood
sera
pcdnan
immun
group
could
strongli
detect
nspecif
protein
wherea
blood
sera
collect
control
group
inocul
pcdna
pb
show
signific
level
immun
respons
p
fig
day
electropor
immun
group
show
detect
level
antibodi
wherea
intramuscularli
oral
immun
group
show
small
quantiti
antibodi
larg
increas
immun
antibodi
observ
sera
immun
group
day
day
second
boost
day
electropor
immun
group
show
highest
antibodi
level
immun
group
p
specif
antibodi
intramuscularli
immun
group
hold
higher
level
howev
antibodi
level
oral
immun
group
reduc
slightli
day
first
immun
immun
process
electropor
group
immun
pcdnan
induc
highest
level
antibodi
oral
immun
group
evok
lowest
level
antibodi
among
three
vaccin
rout
ten
day
final
immun
nspecif
antibodi
subclass
mous
sera
determin
elisa
shown
fig
antin
protein
igg
subtyp
profil
reveal
induc
immun
regimen
three
group
control
anim
show
detectablespecif
antibodi
respons
electropor
immun
group
elicit
vigor
nspecif
antibodi
respons
predominantli
subclass
antibodi
level
produc
anim
two
time
higher
produc
group
p
antibodi
respons
oral
dna
vaccin
induc
slightli
weak
antibodi
respons
compar
two
immun
rout
evok
vigor
subclass
antibodi
level
antibodi
produc
intramuscularli
vaccin
anim
induc
higher
level
subclass
appreci
higher
group
studi
whether
cell
prolifer
could
influenc
via
differ
immun
rout
day
final
immun
splenocyt
obtain
anim
cultur
concentr
cellsml
presenc
gml
purifi
n
protein
h
analyz
antigeninduc
cell
prolifer
result
show
intramuscularli
electropor
oral
dna
vaccin
elicit
vigor
cell
prolifer
respons
shown
fig
higher
level
lymphocyt
stimul
n
protein
observ
mice
immun
fig
nspecif
lymphocyt
prolifer
assay
pool
splenocyt
obtain
mice
mice
per
group
day
final
immun
mice
immun
dna
vaccin
intramuscularli
im
electropor
ie
oral
use
liveattenu
salmonella
typhimurium
oral
splenocyt
stimul
vitro
n
protein
test
group
con
posit
control
bsa
irrelev
antigen
control
splenocyt
control
group
pb
stimul
n
protein
serv
neg
control
sham
control
stimul
index
si
calcul
use
follow
formula
si
mean
od
con
aor
antigenstimul
prolifer
mean
od
nonstimul
prolifer
bar
repres
mean
si
sd
mice
pcdnan
compar
control
p
splenocyt
prolifer
respons
oral
immun
group
high
compar
two
immun
rout
intramuscularli
immun
group
induc
slightli
stronger
cell
respons
electropor
immun
group
result
indic
immun
pcdnan
elicit
recogniz
level
antigenspecif
cell
respons
oral
immun
rout
evok
strongest
immun
respons
elispot
assay
use
assess
magnitud
nspecif
cell
respons
mice
vaccin
ndna
vaccin
splenocyt
vaccin
mice
harvest
day
final
vaccin
nspecif
elispot
enumer
protein
dosag
use
stimul
number
splenocyt
optim
induc
cell
respons
data
shown
elispot
background
count
well
contain
splenocyt
absenc
mitogen
nomin
antigen
cell
data
shown
shown
fig
b
low
number
nonspecif
elispot
detect
control
group
signific
number
nspecif
elispot
detect
immun
group
p
oral
immun
group
induc
significantli
highest
lever
nspecif
compar
induc
immun
electropor
intramuscularli
immun
group
oral
immun
mice
induc
lowest
igg
level
main
isotyp
significantli
elicit
higher
level
intramuscularli
electropor
immun
electropor
group
evok
lowest
level
three
rout
howev
clearli
elev
electropor
vaccin
group
intramuscularli
group
intramuscularli
immun
group
induc
slightli
stronger
wherea
lower
electropor
immun
group
moreov
group
induc
much
higher
level
result
suggest
ndna
vaccin
formul
immunogen
like
induc
stronger
bia
sever
vaccin
rout
dna
vaccin
shown
gener
specif
humor
cellular
respons
howev
studi
directli
compar
immun
respons
gener
differ
vaccin
rout
present
studi
sarscov
n
dna
vaccin
approach
investig
use
three
differ
immun
rout
includ
intramuscularli
electropor
oral
carri
liveattenu
typhimurium
mous
model
clearli
show
administr
n
dna
vaccin
candid
via
differ
immun
rout
could
induc
qualit
differ
immun
respons
profil
former
experi
shown
intramuscularli
vaccin
sarscov
dna
elicit
sarscov
sspecif
humor
cellular
immun
respons
result
also
suggest
respons
could
significantli
enhanc
coadministr
vector
current
studi
util
sarscov
nexpress
plasmid
immun
respons
produc
three
differ
immun
rout
compar
thu
abil
dna
immun
strategi
enhanc
cellular
humor
immun
respons
confirm
two
distinct
system
result
show
immun
intramuscularli
induc
moder
cell
respons
antibodi
respons
predomin
compar
two
immun
group
mice
administr
electropor
induc
highest
antibodi
respons
predomin
among
three
immun
group
midlevel
cellular
respons
contrast
dna
vaccin
deliv
oral
liveattenu
salmonella
evok
vigor
cell
respons
weak
antibodi
product
domin
subclass
result
show
differ
vaccin
rout
gener
distinct
type
immun
respons
antibodi
subclass
cell
respons
style
chang
dna
immun
altern
dose
dna
use
immun
group
data
shown
indic
abil
gener
differ
th
type
due
differ
dose
dna
use
dna
immun
find
import
implic
vaccin
design
studi
mechan
th
cell
differenti
dna
vaccin
attract
increas
attent
due
multipl
advantag
convent
vaccin
attempt
improv
vaccin
immun
effect
focu
enhanc
dna
deliveri
employ
novel
immunoadjuv
electropor
emerg
effect
method
deliv
dna
vaccin
significantli
enhanc
immun
respons
previous
experi
shown
electropor
improv
immunogen
dna
vaccin
mice
guinea
pig
rabbit
rhesu
macaqu
studi
observ
antigenspecif
antibodi
level
induc
electropor
vaccin
higher
seen
two
dna
vaccin
studi
phenomenon
could
explain
follow
firstli
applic
short
electr
puls
target
tissu
render
cell
membran
transient
permeabl
dna
molecul
secondli
muscl
could
damag
site
electropor
took
place
although
damag
observ
minor
sinc
littl
muscl
mass
affect
damag
cell
electropor
releas
danger
signal
attract
antigenpres
cell
immun
cell
result
increas
dna
uptak
lead
enhanc
protein
express
treat
muscl
cell
henc
electropor
may
work
adjuv
increas
immun
respons
ag
produc
anoth
promis
way
deliveri
use
attenu
salmonella
strain
shown
repeatedli
support
result
studi
uniqu
strong
cell
respons
rel
weak
antibodi
respons
elicit
immun
liveattenu
typhimurium
contain
dna
vaccin
present
studi
also
shown
strong
cell
prolifer
respons
associ
administr
liveattenu
typhimurium
contain
dna
vaccin
strong
cell
respons
support
detect
high
level
cytokin
supernat
splenocyt
cultur
deriv
oral
immun
mice
hand
antibodi
respons
induc
liveattenu
typhimurium
carri
dna
vaccin
rel
weak
predominantli
contrast
strong
igg
respons
associ
dna
vaccin
electropor
salmonella
abil
accumul
immun
respons
take
action
lymphat
node
spleen
attenu
salmonella
cell
effect
consum
peripher
phagocyt
cell
penetr
mucosa
mcell
migrat
toward
induct
site
lymphoid
organ
tune
immun
respons
n
peptid
might
cleav
within
cell
present
mhc
class
pathway
give
rise
strong
cellular
respons
time
small
amount
n
peptid
gener
cell
might
secret
present
b
cell
mhc
class
ii
pathway
result
poor
antibodi
respons
note
dna
carri
differ
rout
induc
differ
immun
respons
profil
might
due
differ
way
present
n
antigen
profession
antigenpres
cell
apc
im
electropor
oral
immun
result
show
deliveri
dna
vaccin
electropor
oral
use
liveattenu
salmonella
vivo
effect
method
increas
express
muscl
tissu
lead
mark
improv
immun
respons
addit
base
observ
oral
dna
vaccin
induc
strong
cellmedi
immun
respons
wherea
electropor
immun
induc
moder
cell
vigor
antibodi
respons
studi
carri
use
combin
strategi
oral
electropor
immun
stimul
higher
cellular
humor
immun
respons
dna
vaccin
hold
promis
use
human
howev
immunogen
sarscov
dna
vaccin
human
yet
establish
whether
approach
could
appli
anim
model
still
unknown
immunogen
human
remain
establish
sarscov
vaccin
signific
limit
current
technolog
prevent
full
effect
dna
vaccin
larger
anim
human
safeti
concern
live
viru
therefor
import
evalu
efficaci
sar
dna
vaccin
anim
model
highli
relev
translat
model
demonstr
human
immun
respons
